Skip to main content
Healthcare

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

Feed excerpt — reported by STAT News

AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS. 

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.